| 1981 |
A 72-bp repeated sequence element in SV40 DNA (transcriptional enhancer) acts in cis to increase beta-globin gene transcription ~200-fold; the element functions in either orientation and at positions up to 1400 bp upstream or 3300 bp downstream of the beta-globin transcription initiation site. |
Transient transfection of HeLa cells with beta-globin gene-SV40 recombinant plasmids; S1 nuclease hybridization assay; immunofluorescent staining for beta-globin protein |
Cell |
High |
6277502
|
| 1982 |
Efficient transcription of the rabbit beta-globin gene in vivo requires both the ATA (TATA) box and a region between -100 and -58 bp upstream of the transcription start site; deletion of either region reduces transcript levels ~10-fold, and deletion of the ATA box also abolishes initiation-site specificity. Sequences downstream of the ATA box, including the natural cap site, are dispensable. |
Deletion mutagenesis of the rabbit beta-globin gene introduced into HeLa cells via SV40-plasmid recombinants; S1 nuclease quantitation of beta-globin transcripts |
Nature |
High |
6276753
|
| 1983 |
An SV40-globin hybrid transcript is produced and translated in infected monkey cells only when the construct retains a ~500 bp SV40 RNA splicing region; deletion of this splicing region abolishes stable globin transcript accumulation and beta-globin protein production. |
Construction of SV40-beta-globin recombinant viruses with defined deletions; radioimmunoassay for beta-globin protein; RNA analysis in infected monkey cells |
Cell |
Medium |
225043
|
| 1981 |
The rabbit beta-globin promoter is recognized and transcripts are correctly spliced when the gene is expressed in Xenopus laevis frog embryos, demonstrating conservation of the basic transcriptional and splicing machinery across vertebrates. |
Microinjection of rabbit beta-globin gene into fertilized Xenopus eggs; S1 nuclease mapping of transcripts |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
6946453
|
| 1981 |
The largest beta-globin pre-mRNA is co-linear with the gene and contains both intervening sequences; splicing proceeds stepwise, with removal of the small intron (IVS1) generally preceding removal of the large intron (IVS2), generating partially spliced intermediates. |
S1 nuclease mapping of RNA from rabbit bone marrow |
Cell |
High |
7471214
|
| 1982 |
Human beta-globin pre-mRNA is accurately spliced in vitro by HeLa cell whole-cell extracts; the small intervening sequence is removed precisely, yielding a junction sequence identical to authentic reticulocyte beta-globin mRNA. A transcript terminated upstream of the polyadenylation site is spliced most efficiently, whereas one terminated downstream is not spliced. |
In vitro splicing assay with HeLa cell extracts; primer extension analysis of splice junctions |
Nucleic acids research |
High |
6292841
|
| 1983 |
The human beta-globin promoter and coding sequences are transcribed by RNA polymerase III (in addition to Pol II); these Pol III transcripts are polyadenylated, probably spliced, and detectable in bone marrow and reticulocytes. Their 5' boundaries map near an Alu-related Pol III promoter consensus sequence between -235 and the cap site. |
In vitro transcription with alpha-amanitin sensitivity assay; in vivo RNA analysis in bone marrow and reticulocytes |
Cell |
Medium |
6194893
|
| 1984 |
Induction of beta-globin gene expression in murine erythroleukemia (MEL) cells requires DNA sequences both 5' and 3' of the translation initiation site; hybrid gene experiments show that the 3' beta-globin sequences (coding region) are sufficient to confer inducibility on heterologous promoters, and nuclear run-on confirms induction is at least partly transcriptional. |
Introduction of deletion mutants and hybrid genes (beta/gamma, beta/H-2Kbm1) into MEL cells; S1 nuclease analysis before and after differentiation; nuclear run-on transcription assay |
Cell |
High |
6088069
|
| 1983 |
Induction of the beta-globin gene during MEL cell differentiation results at least in part from increased transcription rate, as shown by nuclear transcription (run-on) experiments; both the intact human beta-globin gene and a hybrid mouse-human beta-globin gene are inducible, indicating the regulatory sequences are conserved between mouse and human. |
Stable cotransformation of MEL cells; S1 nuclease and primer extension analysis; nuclear transcription run-on experiments |
Cell |
High |
6572107
|
| 1985 |
Human beta-globin gene expression in transgenic mice is restricted to erythroid lineage cells; constructs with as little as 48 bp of 5'-flanking sequence drive erythroid-specific, temporally correct expression. mRNA transcripts have correct 5' ends and direct beta-globin protein synthesis, and human beta-globin protein is detectable in mature erythrocytes. |
Pronuclear microinjection to generate transgenic mice; S1 nuclease/primer extension for RNA analysis; reticulocyte lysate translation; protein detection in erythrocytes |
The EMBO journal |
High |
2992937
|
| 1988 |
A chicken erythroid cell-specific enhancer in the intergenic region between adult beta- and embryonic epsilon-globin genes activates transcription of both; correct developmental stage-specific regulation of beta-globin requires interaction of the beta-globin enhancer with a positive regulatory element (the developmental stage selector element, SSE) within the adult beta-globin promoter. |
Deletion and substitution mutant analysis in avian erythroid cells; transient transfection assays |
Cell |
High |
3167976
|
| 1988 |
Premature translation termination (nonsense) mutations in the human beta-globin gene decrease steady-state mRNA levels; this effect is observed for all five nonsense mutations tested (at codons 15, 17, 26, 39, 112) but not for two missense mutations, indicating that the presence of a stop codon per se—regardless of position or type—correlates with reduced mRNA accumulation. |
Heterologous transfection of cloned beta-globin genes carrying defined point mutations; steady-state mRNA quantitation by S1 nuclease assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
3353367
|
| 1992 |
The beta-39 nonsense mutation reduces beta-globin mRNA accumulation at a step prior to cytoplasmic accumulation (i.e., a nuclear/pre-cytoplasmic step); cytoplasmic mRNA stability, splicing accuracy, and polyadenylation are not affected, pointing to a defect in nuclear mRNA metabolism. |
Transfection into cell lines carrying temperature-sensitive RNA Pol II; analysis of transcription rate, mRNA stability, splicing accuracy, and polyadenylation separately |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1557399
|
| 1990 |
Human gamma-to-beta globin switching in transgenic mice is restored when both gamma- and beta-globin genes compete together for interaction with the LCR hypersensitive (HS) sequences; when HS sequences are fused individually to either gene alone, high expression is achieved but temporal specificity is lost, demonstrating that developmental switching results from gene competition for LCR interaction. |
Transgenic mice with LCR HS sequences fused to individual globin genes or combined gamma+beta locus fragments; developmental expression analysis |
Genes & development |
High |
1692558
|
| 1996 |
EKLF (erythroid Krüppel-like factor) is required for beta-globin gene transcription and for stabilizing LCR-beta-globin promoter interaction; in EKLF knockout mice the beta-globin promoter chromatin structure is altered, beta-gene transcription is absent, and gamma-gene transcription increases reciprocally. This demonstrates EKLF plays a major role in gamma/beta competition. |
Compound EKLF knockout / human beta-locus transgenic mice; single-cell transcription analysis; chromatin structure analysis at beta-globin promoter |
Genes & development |
High |
8918890
|
| 1988 |
DNA replication is required for transcriptional activation of the Xenopus beta-globin gene in HeLa cell transfections; replication does not act through covalent template modification or simply by increasing copy number, and only replicating templates are transcribed even when co-transfected with non-replicating templates, indicating a direct mechanistic role for replication in gene activation. |
Transfection of replicating vs. non-replicating Xenopus beta-globin constructs in HeLa cells; co-transfection experiments; copy number analysis |
Molecular and cellular biology |
Medium |
2835669
|
| 1994 |
Assembly of the chick beta-globin gene locus into synthetic nuclei using Xenopus egg extracts in an erythroid protein environment recapitulates tissue-specific chromatin structure and long-range promoter-enhancer interaction, leading to beta-globin gene activation; nucleosome-repressed templates can be reactivated by DNA replication in the presence of staged erythroid proteins via chromatin remodeling at the promoter and re-establishment of distal enhancer-promoter communication. |
Synthetic nuclei reconstitution using Xenopus egg extracts; chromatin assembly; transcription assays with erythroid vs. non-erythroid protein extracts |
Genes & development |
High |
7958909
|
| 1997 |
Novel intergenic nuclear transcripts span the LCR and intergenic regions of the human beta-globin locus in erythroid cells; transient transfection of a beta-globin gene (epsilon, gamma, or beta) induces transcription of the chromosomal LCR and intergenic regions in nonerythroid cells (transinduction) by a mechanism requiring transcription of the plasmid but not protein expression. The plasmid co-localizes with the endogenous locus as shown by in situ hybridization. |
Nuclear run-on transcription analysis; transient transfection; fluorescence in situ hybridization (FISH) for co-localization |
Genes & development |
Medium |
9334315
|
| 2001 |
Nuclear ferritin-H specifically binds the CAGTGC motif at position -153 to -148 bp of the human beta-globin promoter; mutation of this motif reduces binding 20-fold in competition gel-shift assays and abolishes ferritin-H-mediated repression of beta-globin promoter-driven reporter expression in cotransfected cells, demonstrating ferritin-H functions as a sequence-specific repressor of the beta-globin gene. |
Electrophoretic mobility shift assay (EMSA)/competition gel-shift with K562 nuclear extracts and purified human ferritin-H; site-directed mutagenesis of promoter; reporter gene cotransfection with EKLF and ferritin-H expression vectors in CV-1 cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
11481480
|
| 2003 |
An erythroid-specific spatial cluster of cis-regulatory elements (active chromatin hub, ACH) forms around the beta-globin LCR and the active globin gene; the core ACH (HS1-HS6 plus upstream 5'HS-60/-62 and downstream 3'HS1) is developmentally conserved in mice and humans. Individual globin genes switch their physical interaction with this cluster during development correlating with changes in their transcriptional activity; in committed erythroid progenitors prior to beta-globin expression only LCR 5'-side interactions are stably present. |
Chromosome conformation capture (3C); DNase I hypersensitivity; developmental stage analysis in mouse and human erythroid cells |
Nature genetics |
High |
14517543
|
| 2004 |
Thalassemia mutations in the 5'UTR of the human beta-globin gene (+10(-T), +22(G>A), +33(C>G), +(40-43)(-AAAC)) reduce steady-state mRNA levels 15-38%; nuclear run-on experiments show that +10(-T) and +33(C>G) reduce the transcription rate (disrupting downstream promoter sequences), while +22(G>A) primarily acts post-transcriptionally; none affect mRNA transport, 3' end processing, or cytoplasmic stability. |
Stable transfection in MEL cells under LCR control; S1 nuclease/RNA quantitation; nuclear run-on; RNA stability assays; nuclear/cytoplasmic fractionation |
British journal of haematology |
High |
15009072
|
| 2007 |
An intact HS2 enhancer that recruits RNA Pol II is required for intergenic transcription and histone H3 acetylation and H3K4 methylation between the enhancer and the epsilon-globin target gene; however, intergenic transcription and histone modifications are not sufficient for target gene transcription, which additionally requires initiation at the TATA box of the target gene—indicating intergenic and genic transcription complexes are independent. |
Chromatin immunoprecipitation (ChIP) for H3 acetylation and H3K4 methylation; model locus with HS2-epsilon-globin in chromatin; enhancer deletion analysis |
Molecular and cellular biology |
High |
17283048
|
| 2010 |
PRMT1-catalyzed asymmetric dimethylation of H4R3 at the beta-globin locus directly enhances histone H3 acetylation (Lys9/Lys14) in vitro by providing a binding surface for PCAF; these modifications are required for efficient LCR-beta-promoter looping, transcription complex recruitment, and beta-globin transcription. PRMT1 knockdown prevents H3 acetylation, LCR-promoter interaction, and erythroid differentiation, all rescued by re-introduction of PRMT1. |
In vitro histone acetyltransferase assay with dimethyl-H4R3 substrate; co-immunoprecipitation of PCAF with modified H4R3; shRNA knockdown of PRMT1 in MEL erythroid progenitors; ChIP; 3C for LCR-promoter interaction; rescue experiment with rat PRMT1 |
Blood |
High |
20068219
|
| 2010 |
KLF1 knockdown in human and mouse adult erythroid progenitors markedly reduces BCL11A expression and increases gamma-globin/beta-globin expression ratios, indicating KLF1 controls globin switching by directly activating beta-globin and indirectly repressing gamma-globin through BCL11A. |
shRNA knockdown of KLF1 in human and mouse adult erythroid progenitors; quantitative RT-PCR for BCL11A, gamma-globin, and beta-globin |
Nature genetics |
High |
20676097
|
| 2011 |
Upon erythroid differentiation, cohesin and its loading factor Nipbl bind the beta-globin LCR and the activated globin gene; Nipbl-dependent cohesin binding is required for long-range chromatin interactions between CTCF insulator elements and between the LCR distal enhancer and the target globin gene, the latter being critical for globin gene expression in vivo and in vitro. |
ChIP for cohesin and Nipbl occupancy; chromosome conformation capture (3C); siRNA knockdown of Nipbl; analysis in differentiating MEL and primary erythroid cells |
The Journal of biological chemistry |
High |
21454523
|
| 2013 |
Three peripheral targeting regions (PTRs) in the HBB BAC drive nuclear peripheral localization of the beta-globin locus; targeting to both peripheral and pericentric heterochromatin depends on Suv39H-mediated H3K9me3 methylation across hundreds of kilobases around HBB, and peripheral tethering of the endogenous HBB locus additionally requires G9a-mediated H3K9me2 in flanking lamin-associated domains. |
BAC transgenesis; FISH; siRNA knockdown of Suv39H and G9a; chromatin fractionation; ChIP for H3K9me2/3 |
The Journal of cell biology |
High |
24297746
|
| 1998 |
Replacement of the murine beta-globin genes with the human betaIVS-2-654 C>T thalassemic gene by gene targeting shows that this mutation causes the same aberrant RNA splicing in mice as in humans; no homozygous mice survive postnatally, and heterozygotes show reduced mouse beta-globin, no human beta-globin, and moderate beta-thalassemia. |
Homologous recombination gene targeting in mouse embryonic stem cells ('plug and socket' method); RNA splicing analysis; hematological characterization of heterozygous mice |
Blood |
High |
9490703
|
| 2002 |
A T>G mutation at nucleotide 705 of human beta-globin intron 2 creates an aberrant 5' splice site that dominates over the correct splice sites; at temperatures below 30°C this aberrant splicing is inhibited and correct splicing is restored, demonstrating that temperature is a parameter affecting splice site selection in this thalassemic context. |
Stable cell lines (HeLa, K562) carrying IVS2-705 or IVS2-745 beta-globin constructs; culture at varying temperatures; RT-PCR analysis of splicing products |
Nucleic acids research |
Medium |
12409448
|
| 1995 |
The second intron (IVS2) of the human beta-globin gene contains four GATA-1 binding sites, two Oct-1 binding sites, two SATB1 binding sites, and a potential homeobox protein binding site, as identified by DNase I footprinting and EMSA of the entire IVS2. |
DNase I footprinting of entire beta-globin IVS2; electrophoretic mobility shift assay (EMSA); antibody supershift for GATA-1, NFE-2, YY1, Oct-1 |
The Journal of biological chemistry |
Medium |
7499351
|
| 2019 |
CRISPR/Cas9 (targeting IVS1-110G>A mutation) and Cas12a/Cpf1 (targeting IVS2-654C>T mutation) RNP complexes achieve high-efficiency disruption of aberrant splice sites in primary CD34+ HSPCs from beta-thalassemia patients; erythroid progeny of edited cells show reversal of aberrant splicing and restoration of beta-globin expression. |
CRISPR RNP electroporation into primary CD34+ HSPCs; erythroid differentiation; RT-PCR for splicing; globin chain HPLC for beta-globin protein restoration |
Blood |
High |
30704988
|
| 2020 |
CRISPR-Cas9-mediated reduction of beta-globin in differentiating erythroid precursors is sufficient to induce robust re-expression of gamma-globin; RNA-seq identifies ATF4 as a causal regulator of this stress response—ATF4 binds the HBS1L-MYB intergenic enhancer and regulates MYB, which in turn controls BCL11A and gamma-globin levels. |
CRISPR-Cas9 knockout of HBB in isogenic erythroid precursors; RNA-seq; ATF4 ChIP at HBS1L-MYB enhancer; quantitation of MYB, BCL11A, and globin expression |
Cell reports |
Medium |
32755585
|
| 2024 |
HBB (hemoglobin subunit beta) is a direct molecular target of aconitine (AC) in cell-free hemoglobin; AC binding to HBB enhances HBB-ABHD5 and HBB-AMPK binding, leading to decreased HDAC-NT generation and cardiomyocyte death. HBB overexpression exacerbates AC-induced cardiotoxicity while HBB knockdown attenuates cardiomyocyte death. AC-triggered hemolysis releases HBB which scavenges NO, decreasing cardioprotective S-nitrosylation. |
RNA-seq in DO mice; HBB overexpression and knockdown in cardiomyocytes; cell-free binding assay for AC-HBB interaction; co-immunoprecipitation of HBB with ABHD5 and AMPK; measurement of S-nitrosylation and HDAC-NT |
Acta pharmacologica Sinica |
Medium |
38467717
|
| 2016 |
The beta subunit of hemoglobin (HBB) acts as a lung-derived antimetastatic factor; a short C-terminal peptide region (Metox) is responsible for activity. HBB and the Metox peptide mediate growth arrest and apoptosis of neuroblastoma and other cancer cell lines in vitro, and Metox administration in xenograft models limits adrenal tumor development and spontaneous lung and bone marrow metastases. HBB2 is produced by alveolar epithelial and endothelial cells and is upregulated in mice bearing undetectable metastases. |
Peptide mapping/fractionation of lung-derived soluble factors; in vitro viability/apoptosis assays; xenograft mouse models; IHC/expression studies for cellular source |
Cancer research |
Medium |
27793844
|
| 2010 |
HBB (beta-globin) mRNA and protein are expressed in neurons of the brain and are increased in the perihematomal zone after intracerebral hemorrhage; hemin upregulates HBB mRNA in cultured neurons, and this is reduced by the iron chelator deferoxamine, indicating a role for iron/heme signaling in neuronal HBB regulation. |
In vivo ICH rat model with time-course; in vitro cultured neurons exposed to hemin ± deferoxamine; qRT-PCR and Western blot; immunolocalization |
Translational stroke research |
Low |
20563289
|